Omnicell | OMCL - Cash And Equivalent


Omnicell reported $180.05M in Cash and Equivalent for its fiscal quarter ending in September of 2025.





Cash And Equivalent Change Date
AppLovin 1.67B 474.29M Sep/2025
Becton, Dickinson and Co. USD 641M 94M Sep/2025
Cardinal Health USD 4.59B 719M Sep/2025
Cerillion plc GBP 23.64M 1.09M Dec/2023
IQVIA Holdings USD 1.81B 225M Sep/2025
McKesson USD 2.96B 1.05B Dec/2025
Omnicell USD 180.05M 218.95M Sep/2025
Stanley Black & Decker USD 280.1M 11.8M Dec/2025
Steris USD 423.7M 104.5M Dec/2025
Veeva Systems USD 1.66B 270.29M Sep/2025